Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Innate Pharma SA ( (FR:IPH) ).
Innate Pharma announced on April 13, 2026 that it will hold its Annual General Meeting of shareholders on May 21, 2026 at its headquarters in Marseille, with proceedings also broadcast live online. The notice, including agenda and proposed resolutions, was published the same day in France’s official legal bulletin, and related documents will be made available on the company’s investor website in line with regulatory requirements.
The company detailed participation rules, including share registration by May 14, 2026 and procedures for bearer shareholders to obtain proof of ownership, as well as the deadline of May 15, 2026 for written shareholder questions. Innate Pharma also plans a guided tour of its laboratories for shareholders on the morning of the meeting, underscoring efforts to deepen investor engagement and transparency around its cancer immunotherapy pipeline and operations.
The most recent analyst rating on (FR:IPH) stock is a Hold with a EUR3.10 price target. To see the full list of analyst forecasts on Innate Pharma SA stock, see the FR:IPH Stock Forecast page.
More about Innate Pharma SA
Innate Pharma S.A. is a global clinical-stage biotechnology company focused on developing immunotherapies for cancer patients. Leveraging antibody engineering and novel target identification, it is advancing next‑generation antibody therapeutics such as IPH4502 for solid tumors, lacutamab for T‑cell lymphomas and monalizumab, partnered with AstraZeneca, for non‑small cell lung cancer.
The Marseille‑based company collaborates with major biopharmaceutical partners including Sanofi and AstraZeneca as well as leading academic institutions to drive innovation in immuno‑oncology. Innate Pharma is listed on Euronext Paris and Nasdaq and operates from its headquarters in France with a U.S. office in Rockville, Maryland.
YTD Price Performance: -27.47%
Average Trading Volume: 195,979
Technical Sentiment Signal: Sell
Current Market Cap: €109M
Learn more about IPH stock on TipRanks’ Stock Analysis page.